Search results for: “pharma sector analysis”
-
Fabtech Technologies IPO Listing: A Muted Debut for the Biopharma Engineering Company
Fabtech Technologies Ltd. made a muted debut on the stock market, listing nearly the same to the IPO price. Get the latest updates on the company’s performance and its implications for Indian investors.
-
Rubicon Research IPO: A Game-Changer for Indian Pharmaceutical Industry
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what you need to know about this highly anticipated IPO.
-
Prasol Chemicals Files for Rs 500 Crore IPO: What Indian Investors Need to Know
Prasol Chemicals Ltd. has filed for an initial public offering worth Rs 500 crore. Here’s what Indian investors should know about the company and its IPO plans.
-
Sensex Today: Nifty Dips Below 24,650, RBI Holds at 5.50% — What’s Next?
Sensex today: Nifty below 24,650, RBI holds repo rate at 5.50%, auto & pharma in focus—get expert analysis and investing insight. Have you ever felt like the pulse of the markets moves faster than your heartbeat? That’s how Indian equity investors have been feeling lately—volatile, unpredictable, and deeply influenced by global news. Sensex today updates…